DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/hshg6b/retinal_vein) has announced the addition of the “Retinal Vein Occlusion – Pipeline Review, H1 2015” report to their offering. This report provides comprehe…
Category: News
Clinical data demonstrates safe administration of Pexa-Vec in patients with metastatic colorectal cancer
SillaJen, Inc., a private clinical-stage biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, today announced a publication of data demonstrating that in a Phase Ib trial of Pexa-Vec, patients received mult…
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (the “Company”), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that Julie McHugh and Michael M. du Toit have been elected to the Company’s Board of Directors. Both individuals bring extensive senior healthcare-focused leadership experience, Ms. McHug
NightstaRx and The University of Alberta announce the start of the first Canadian gene therapy study to treat Choroideremia
NightstaRx Ltd (“Nightstar”), the biopharmaceutical company specialising in bringing therapies for retinal dystrophies to patients, announces that the University of Alberta, has begun enrolling and…
Closing the eye health gap may be in sight, Australia
Three years after the launch of the roadmap to close the gap for vision, progress has been made but “much remains to be done”, according to the authors of a Perspective published online by the…
Intraocular Pressure Elevations Common After Intravitreal Triamcinolone Injections
Intraocular pressure elevations are common after intravitreal injections of triamcinolone acetonide for macular edema resulting from retinal vein occlusion, according to data from the SCORE study. Reuters Health Information
Topical Cyclosporine Better for Ocular Rosacea
A new comparative study has found that topical cyclosporine is more effective than oral doxycycline at relieving symptoms and treating eyelid and dry eye signs in patients with ocular rosacea. Medscape Medical News
Updated Guidelines Issued for Intravitreal Injections
An expert panel offers their thoughts on the best techniques and monitoring strategies from pre- to post-injection. Medscape Ophthalmology
Eye Bleeds: Risk from Warfarin Transition?
(MedPage Today) — Three vitreous hemorrhage cases seen in patients during switch to rivaroxaban.
Innovative gene transfer-based treatment for kids with giant axonal neuropathy
University of North Carolina School of Medicine researchers have developed an innovative, experimental gene transfer-based treatment for children with giant axonal neuropathy (GAN).
Research and Markets: EpiCast Report: Glaucoma – Epidemiology Forecast to 2023
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z46fl6/epicast_report) has announced the addition of the “EpiCast Report: Glaucoma – Epidemiology Forecast to 2023” report to their offering. Glaucoma is a common…
A Young Man With Visual Field Defects
A 28-year-old man who is experiencing reduced vision in his left eye is found to have optic disc edema. What is the most likely diagnosis? Medscape Ophthalmology
Make the Diagnosis: Painful red eye
(MedPage Today) — Case Study: A 29 year old contact lens wearer presents to urgent care with a red eye, pain, and visual loss that has been increasing over the past twelve hours. Examination shows injected conjunctiva with ciliary flush, and a cornea …
Second Sight Appoints Will McGuire as President and CEO
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today anno…
What’s new in contact lenses? Prescribing trends reflect new lens materials and designs
More Americans are using soft contact lenses — especially daily disposable lenses — and taking advantage of new designs targeting vision problems that were difficult to correct with previous…
Diabetic blindness: UVA IDs best source of stem cells to block vision loss
Evaluation a key step in creation of treatment for disease that affects millionsUniversity of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use…
Innovative formula prevents risks, painful treatments in people with secondary blindness
The Mexican company “Medical and Surgical Center for Retina” created a way to transport drugs, in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative blindness such as diabetic retinopathy and dege…
Plugging the Tear Ducts Helps Some With Dry Eyes
Tiny plugs inserted into the tear duct may safely curb the annoying and damaging effects of dry eyes, according to a new analysis of previous research. Reuters Health Information
The New MCAT: Is It Right for Tomorrow’s Physicians?
A new version of the Medical College Admission Test (MCAT) debuted this past April. Is it an improvement on prior versions, and is it the best means to assess future physicians? Medscape Med Students
Eleven Biotherapeutics Announces Executive Change
CAMBRIDGE, Mass.–(BUSINESS WIRE)–John McCabe, Eleven’s VP, Finance and Business Operations, is promoted to assume the roles of Principal Financial Officer and Principal Accounting Officer, reporting directly to Abbie Celniker, PhD.